How We Carried Out Identification of an Unknown Impurity in a Phase 3 API Using LC-MS/MS & NMR
Introduction: Why Identification of an Unknown Impurity is Critical in Phase 3 Drug Development In late-stage pharmaceutical development, identification of […]









